Clinical studies recruiting near Doral

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · D&H Doral Research Center · Philip Morris Products S.A. · NCT07108166 Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Phase 2 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06989359 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · UM Sylvester Comprehensive Cancer Center at Doral · National Cancer Institute (NCI) · NCT06860594 A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Phase 2 · Research Site 102 · Locus Biosciences · NCT05488340 Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-
Phase 3 · UM Sylvester Comprehensive Cancer Center at Doral · NRG Oncology · NCT06500481 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · UM Sylvester Comprehensive Cancer Center at Doral · Alliance for Clinical Trials in Oncology · NCT06876714 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · St. Jude Clinical Research- Site Number : 8400049 · Sanofi · NCT07290803 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · UM Sylvester Comprehensive Cancer Center at Doral · Canadian Cancer Trials Group · NCT06592924 eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07177339 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · UM Sylvester Comprehensive Cancer Center at Doral · NRG Oncology · NCT03180268 Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Phase 3 · D&H Doral Research Center · Sun Pharmaceutical Industries, Inc. · NCT07133308 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Phase 2 · AMR Clinical · Eli Lilly and Company · NCT07219173 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Integrity Clinical Research LLC - 21st Street · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Phase 3 · UM Sylvester Comprehensive Cancer Center at Doral · NRG Oncology · NCT05646316 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · Local Institution - 2636 · Bristol-Myers Squibb · NCT07011745 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · UM Sylvester Comprehensive Cancer Center at Doral · NRG Oncology · NCT04852887 Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GL
Phase 2 · DM Clinical Research - MIA · Veru Inc. · NCT07446998 RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated
Phase 2 · Altimmune Clinical Study Site · Altimmune, Inc. · NCT07009860 A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Phase 4 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06223880 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · St. Jude Clinical Research- Site Number : 8401287 · Sanofi · NCT06241118 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · AMR Clinical · Eli Lilly and Company · NCT07392190 A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' D
Phase 2 · Site Number - 1024 · Immunovant Sciences GmbH · NCT07018323 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1045 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363 Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Phase 3 · Site-052 · Biohaven Therapeutics Ltd. · NCT07661056 A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
Phase 4 · Bausch Site 07 · Bausch Health Americas, Inc. · NCT03987763 Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Phase 3 · Dr. Falk Investigational Site · Dr. Falk Pharma GmbH · NCT06596252 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Dia
Phase 3 · Research Site · AstraZeneca · NCT07664553 A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and
Phase 2 · Universal Axon Clinical Research · Novartis Pharmaceuticals · NCT07610278 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Phase 3 · Research Site 12 · Generate Biomedicines · NCT07276724

Look up another city

Look up another condition